약물전달 기술 시장 : 투여 경로별, 치료 영역별, 최종사용자별, 지역별

Global Drug Delivery Technologies Market is estimated to be valued at USD 49.79 Bn in 2025 and is expected to reach USD 116.49 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.9% from 2025 to 2032.

Figure. Drug Delivery Technologies Market Share (%), By Region 2025

Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Various drug delivery technologies have been developed to improve efficacy and safety of drug molecules by protecting them from degradation and controlling their release rates. Advancements in areas such as immunotherapy, gene therapy, and precision medicine have fueled the demand for more effective drug delivery methods. The market has witnessed innovation of novel drug carrier systems such as liposomes, microspheres, nanocarriers, and other that can efficiently deliver drugs to targeted sites in the body. Furthermore, rising prevalence of chronic diseases, growth of biologics market, and increased R&D investments from key players in this field are some of the key factors expected to drive market growth during the forecast period.

Market Dynamics:

Global drug delivery technologies market is primarily driven by the rising global prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases. In September 2023, according to the World Health Organization (WHO), chronic diseases accounted for approximately 60% of all reported deaths in the world in 2020. Drug delivery systems help improve the efficacy of pharmaceutical therapies and clinical outcomes of chronic patients. Furthermore, growth of the biologics market has also created opportunities for advanced drug delivery approaches for large molecule biotherapeutics. However, high costs associated with the R&D and manufacturing of novel drug delivery systems may hinder the market growth during the forecast period. Advancements in areas of nanomedicine, injectable drug delivery, and 3D printing offer lucrative opportunities for market expansion.

Key Features of the Study:

This report provides in-depth analysis of the global drug delivery technologies market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global drug delivery technologies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Johnson & Johnson Pvt. Ltd., Pfizer Inc., Novartis AG, Merck & Co., Inc., GlaxoSmithKline PLC, Sanofi S.A., Bayer AG, Abbott Laboratories, 3M Company, Antares Pharma, Alkermes PLC, Vectura Group PLC, Generex Biotechnology Corporation, F. Hoffmann-La Roche Ltd., and Medtronic PLC

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global drug delivery technologies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug delivery technologies market

Market Segmentation

• Route of Administration Insights (Revenue, USD Bn, 2019 - 2032)
  • Oral
  • Parenteral
  • Intramuscular
  • Intravenous
  • Intra-Arterial
  • Subcutaneous
  • Nasal Drug Delivery
  • Ocular Drug Delivery
  • Topical/Transdermal
• Therapeutic Area Insights (Revenue, USD Bn, 2019 - 2032)
  • Oncology
  • Cardiology
  • Neurology
  • Immunology
  • Rheumatology
  • Diabetes
  • Others (Infectious Diseases, etc.)
• End User Insights (Revenue, USD Bn, 2019 - 2032)
  • Ambulatory Surgical Clinics
  • Diagnostic Centers
  • Hospitals
  • Homecare Settings
  • Others
• Regional Insights (Revenue, USD Bn, 2019 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Johnson & Johnson Pvt. Ltd.
  • Pfizer Inc.
  • Novartis AG
  • Merck & Co., Inc.
  • GlaxoSmithKline PLC
  • Sanofi S.A.
  • Bayer AG
  • Abbott Laboratories
  • 3M Company
  • Antares Pharma
  • Alkermes PLC
  • Vectura Group PLC
  • Generex Biotechnology Corporation
  • F. Hoffmann-La Roche Ltd.
  • Medtronic PLC

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Drug Delivery Technologies Market, By Route of Administration
  • Global Drug Delivery Technologies Market, By Therapeutic Area
  • Global Drug Delivery Technologies Market, By End User
  • Global Drug Delivery Technologies Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Drug Delivery Technologies Market, By Route of Administration, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Parenteral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Intramuscular
  • Intravenous
  • Intra-Arterial
  • Subcutaneous
• Nasal Drug Delivery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ocular Drug Delivery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Topical/Transdermal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Drug Delivery Technologies Market, By Therapeutic Area, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cardiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Immunology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Rheumatology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (Infectious Diseases, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Drug Delivery Technologies Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Ambulatory Surgical Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Homecare Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Drug Delivery Technologies Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Route of Administration , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Route of Administration , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Route of Administration , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Johnson & Johnson Pvt. Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GlaxoSmithKline PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanofi S.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
• 3M Company
• Antares Pharma
• Alkermes PLC
• Vectura Group PLC
• Generex Biotechnology Corporation
• F. Hoffmann-La Roche Ltd.
• Medtronic PLC

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us